June 26 is National Cancer Wellness Awareness Day. Shaare Zedek Medical Center in Jerusalem is developing an AI (Artificial Intelligence)-based tool, named I3LUNG that can predict the effects of immunotherapy on lung cancer patients.
#LungCancerResearch #AI #Israel #Innovation

This year again, in sync with the XMas countdowm, we are lucky to witness the migration of the wild Milanese Panettone to its natural habitat - late-working offices. Majestic as ever.

And yes, it's still crunch time to finish up I3LUNG 's models ! Hanging in there. #AIResearch

💬”Disparities between high and low income countries can be large when talking about advanced technologies (AI). However, investment now can lower the cost later.”
Excellent presentation by arsela prelaj from I3LUNG about lung cancer, use of AI, and disparities in #cancer 👏🏼

Another week, another couple of lab meetings on I3LUNG's model and our tools for #NSCLC patients. Should cook up a formula for the correlation between the number of round-tables, office lunches and the amount of scribbles on the whiteboards.

Another week, another lab meeting picture. The spooky season is behind us and we're looking forward to Christmas, but the @I3LUNG (and more !!) deadlines crunch time is still just as scary - something's not right🤔
Also, running out of whiteboard space. And chairs. #AIresearch

Spending quality time in between science at #ESMO2023 with italian friends: arsela prelaj beautiful collaboration & friendship built up through #I3Lung & my longstanding YOC buddy, dearest friend over years & through wonderful projects Marina Garassino lovely to see you again❤️

What’s the role of #ArtificialIntelligence in #lungcancer diagnosis & treatment?

Perhaps more than we think in future as discussed at I3LUNG Lung Cancer Europe workshop.

Important data showing that lung cancer is not an old person’s disease: majority dx between 45-69 years

👇 #LCSM

Che cos’è il progetto europeo I3LUNG?

Ce lo racconta la Dott.ssa Valeria Sebri, ricercatrice, psicologa e psicoterapeuta in IEO.💙

👉Guarda il video per saperne di più

#IEO #IEO alvostrofianco #psiconcologia

We represent the voice of Europeans impacted by lung cancer and actively participate in impactful projects under the Horizon Europe framework. Join us in our initiatives like I3LUNG and @HorizonInspire.
i3lung.eu
horizon-inspire.eu
#HorizonEurope #EU4Health

Very proud of my friend and colleague arsela prelaj, an inspiring example of determination and positivity.
Keep rocking! #LCSM
corriere.it/sette/attualit…
I3LUNG
Istituto Tumori
Corriere della Sera

Honored to participate in this secondary multiomic analysis of the PEOPLE trial, looking for predictors of immunotherapy response in advanced NSCLC, with arsela prelaj and Marina Garassino. Looking forward to carrying this work forward as we study IO response through I3LUNG!

#ASCO23 #ai #ai medsm Prelaj: AI #deeplearning can be applied to many aspects of oncology, including screening/dx, treatment selection, predicting tx outcome and AEs, and prediction of relapse. I3LUNG a project using multiomic data to build ML model of NSCLC.

The 16 partners of the @I3LUNG European project, including MEDSIR, met this weekend in Barcelona for our Annual Meeting to share the progress made in #ArtificialIntelligence applied to #lungcancer .

Learn more: medsir.org/post/we-are-pa…

#I3LUNG #EUFunded #EU4Health HaDEA

Hard work on data curation preparing the first I3LUNG tool.

🔵 Cáncer de Pulmón ha participado en el proyecto I3LUNG que tiene como objetivo conseguir un tratamiento personalizado basado en la inteligencia artificial para pacientes de #cáncerdepulmón

🔹️de células no invasivas
🔹️con metástasis
🔹️pueden recibir inmunoterapia

arsela prelaj parla di AI in oncologia a 50mo congresso l AIOM. Un grande passo avanti rispetto al passato. Dalla teoria alla pratica con la presentazione dello studio I3LUNG a cui anche il Istituto Mario Negri collabora Istituto Tumori

The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy arsela prelaj clinical-lung-cancer.com/article/S1525-…

MEDSIR and I3LUNG Partners Meet to Advance the Application of AI to Lung Cancer

viv-media.com/infozx-288579-…

Tumore al polmone, con l'AI verso una terapia personalizzata.
L'Istituto Nazionale dei Tumori di Milano è capofila del progetto internazionale di ricerca I3LUNG finanziato con 10 milioni di euro dall'Ue.
ansa.it/canale_salutee…